A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients | Journal of Nanobiotechnology | Full Text https://t.co/Z6fbDimUnJ
26 followers
232 followers
A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients. https://t.co/04t0gQ3j3e
5,751 followers
Top story: A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients | Journal of Nanobiotechnology… https://t.co/ruCzNqO1iT, see more h
3,202 followers
J Nanobiotechnology A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients: Currently, the main goal… https://t.co/xbDhmUrNxt #Resear